CAR T-cell therapy shows potential in treating solid tumours

A US biotech company claims to have made the game-changing leap of using CAR T-cell therapy to treat solid tumours. Presenting ‘proof of concept’ research findings at the CAR-TCR Summit in Boston on September 5, the California-based Eureka Therapeutics said it had achieved encouraging results in six patients with liver cancer using a novel approach ...